Literature DB >> 9545263

FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking.

A Melendez1, R A Floto, D J Gillooly, M M Harnett, J M Allen.   

Abstract

Aggregation of receptors specific for the constant region of immunoglobulin G activates a repertoire of monocyte responses that can lead ultimately to targeted cell killing via antibody-directed cellular cytotoxicity. The high affinity receptor, FcgammaRI, contains no recognized signaling motif in its cytoplasmic tail but rather utilizes the gamma-chain of FcepsilonRI as an accessory molecule to recruit tyrosine kinases for signal transduction. We show here that, in a human monocytic cell line primed with interferon-gamma, FcgammaRI mobilizes intracellular calcium stores using a novel pathway that involves tyrosine kinase coupling to phospholipase D and resultant downstream activation of sphingosine kinase. Moreover, FcgammaRI is not coupled to phospholipase C; hence, calcium release from intracellular stores occurred in the absence of any measurable rise in inositol triphosphate. Finally, as this novel activation pathway is also shown to be responsible for mediating the vesicular trafficking of internalized immune complexes for degradation, it is likely to play a key role in controlling intracellular events triggered by FcgammaRI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545263     DOI: 10.1074/jbc.273.16.9393

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Endocytosis and vesicular trafficking of immune complexes and activation of phospholipase D by the human high-affinity IgG receptor requires distinct phosphoinositide 3-kinase activities.

Authors:  D J Gillooly; A J Melendez; A R Hockaday; M M Harnett; J M Allen
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 2.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

3.  Cross-linking of FcepsilonRI causes Ca2+ mobilization via a sphingosine kinase pathway in a clathrin-dependent manner.

Authors:  Seung-Duk Ryu; Hyun Sil Lee; Ho Young Suk; Chang-Shin Park; Oksoon Hong Choi
Journal:  Cell Calcium       Date:  2009-02       Impact factor: 6.817

4.  The human high-affinity immunoglobulin G receptor activates SH2-containing inositol phosphatase (SHIP).

Authors:  A J Cameron; J M Allen
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

5.  Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death.

Authors:  S M Mandala; R Thornton; I Galve-Roperh; S Poulton; C Peterson; A Olivera; J Bergstrom; M B Kurtz; S Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

6.  Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival.

Authors:  Johnny H Chen; Maziar Riazy; Shih Wei Wang; Jiazhen Minnie Dai; Vincent Duronio; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

7.  Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis.

Authors:  Weicheng Wu; Raymond D Mosteller; Daniel Broek
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 8.  Regulation of Ca2+ signaling with particular focus on mast cells.

Authors:  Hong-Tao Ma; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

9.  Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages.

Authors:  Samar M Hammad; Heather G Crellin; Bill X Wu; Jessica Melton; Viviana Anelli; Lina M Obeid
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-11-24       Impact factor: 3.072

10.  Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

Authors:  Masahito Kawabori; Rachid Kacimi; Joel S Karliner; Midori A Yenari
Journal:  World J Cardiol       Date:  2013-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.